APOE does not predict poor outcome 1 year after ischemic stroke

Neurological Research

Volumn 29, Issue 1, 2007, Pages 64-69

  Sarzyńska Długosz, Iwona ^a   Gromadzka, Grazyna ^a,b   Barańska Gieruszczak, Maria ^a   Ciesielska, Agnieszka ^a,b   Członkowska, Anna ^a,b  

^a INSTITUTE OF PSYCHIATRY AND NEUROLOGY   (Poland)

^b MEDICAL UNIVERSITY OF WARSAW   (Poland)

Author keywords

Apolipoprotein E; Ischemic stroke; Mortality; Poor outcome

Indexed keywords

ADULT; AGED; APOE GENE; ARTICLE; CEREBROVASCULAR ACCIDENT; CONGESTIVE HEART FAILURE; CONSCIOUSNESS DISORDER; FEMALE; GENE; GENETIC ASSOCIATION; GENETIC EPIDEMIOLOGY; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENOTYPE PHENOTYPE CORRELATION; HEART ATRIUM FIBRILLATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTCOME ASSESSMENT; PARESIS; POLYMERASE CHAIN REACTION; PREDICTION; RANKIN SCALE; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RISK FACTOR; SURVIVAL TIME;

AGE DISTRIBUTION; AGE FACTORS; AGED; AGED, 80 AND OVER; APOLIPOPROTEINS E; BRAIN ISCHEMIA; CEREBROVASCULAR ACCIDENT; COMORBIDITY; CONSCIOUSNESS DISORDERS; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENETIC SCREENING; GENOTYPE; HEART FAILURE, CONGESTIVE; HUMANS; MALE; MIDDLE AGED; PARESIS; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROSPECTIVE STUDIES; SURVIVAL RATE; TIME FACTORS;

EID: 33846632790     PISSN: 01616412     EISSN: None     Source Type: Journal    
DOI: 10.1179/174313206X152528     Document Type: Article

References (37)

1. Anderson CS, Jamrozik KD, Broadhurst RJ, et al. Predicting survival for 1 year among different subtypes of stroke: Results from the Perth Community Stroke Study. Stroke 1994; 25: 1935-1944
2. Appelros P, Nydevik I, Viitanen M. Poor outcome after first-ever stroke. Predictors for death, dependency, and recurrent stroke within the first year. Stroke 2003; 34: 122-126
3. Chambers BR, Norris JW, Shurvell BL, et al. Prognosis of acute stroke. Neurology 1987; 37: 221-225
4. Petty GW, Brown RD, Jr, Whisnant JP, et al. Survival and recurrence after first cerebral infarction, A population-based study in Rochester, Minnesota, 1975 through 1989. Neurology 1998; 50: 208-216
5. Sacco RL, Wolf PA, Kannel WB, et al. Survival and recurrence following stroke: The Framingham Study. Stroke 1982; 13: 290-295
6. Vemmos KN, Bots ML, Tsibouris PK, et al. Prognosis of stroke in the south of Greece: 1 year mortality, functional outcome and its determinants: The Arcadia Stroke Registry. J Neurol Neurosurg Psychiatry 2000; 69: 595-600
7. Viitanen M, Eriksson S, Asplund K, et al. Determinants of long-term mortality after stroke. Acta Med Scand 1987; 221: 349-356
8. Burn J, Sandercock P. Predicting the outcome of acute stroke. J Neurol Neurosurg Psychiatry 1993; 56: 576
9. Fiorelli M, Alperovitch A, Argentino C, et al. Prediction of long-term outcome in the early hours following acute ischemic stroke: Italian Acute Stroke Study Group. Arch Neurol 1995; 52: 250-255
10. Hénon H, Godefroy O, Leys D, et al. Early predictors of death and disability after acute cerebral ischemic event. Stroke 1995; 26: 392-398
11. Basun H, Corder EH, Guo Z, et al. Apolipoprotein E polymorphism and stroke in a population aged 75 years or more. Stroke 1996; 27: 1310-1315
12. Casas JP, Hingorani A, Bautista LE, et al. Meta-analysis of genetic studies in ischemic stroke: Thirty-two genes involving approximately 18000 cases and 58000 controls. Arch Neurol 2004; 61: 1652-1661
13. Coria F, Rubio I, Nuňez E, et al. Apolipoprotein E variants in ischemic stroke. Stroke 1995; 26: 2375-2376
14. Kuusisto J, Mikkänen L, Kervinen K, et al. Apolipoprotein E4 phenotype is not an important risk factor for coronary heart disease or stroke in elderly subjects. Arter Thromb Vasc Biol 1996; 15: 1280-1286
15. McCarron MO, Weir CJ, Muir KW, et al. Effect of apolipoprotein E genotype on in-hospital mortality following intracerebral haemorrhage. Acta Med Scand 2003; 107: 106-109
16. Crawford FC, Vanderploeg RD, Freeman MJ, et al. APOE genotype influences acquisition and recall following traumatic brain injury. Neurology 2002; 58: 1115-1118
17. Liberman JN, Stewart WF, Wesnes K, et al. Apolipoprotein E epsilon 4 and short-term recovery from predominantly mild brain injury. Neurology 2002; 58: 1038-1044
18. Wang JC, Kwon JM, P Shah, et al. Effect of APOE genotype and promoter polymorphism on risk of Alzheimer's disease. Neurology 2000; 55: 1644-1649
19. Fazekas F, Strasser-Fuchs S, Kollegger H, et al. Apolipoprotein E E ε4 is associated with rapid progression of multiple sclerosis. Neurology 2001; 57: 853-857
20. Rail SC, Jr, Weisgraber KH, Mahley RW. Human apolipoprotein E. The complete amino acid sequence. J Biol Chem 1982; 257: 4171-4178
21. Alberts MJ, Graffagnino C, McClenny C, et al. ApoE genotype and survival from intracerebral hemorrhage. Lancet 1995; 346: 575
22. Teasdale GM, Nicoll JAR, Murray G, et al. Association of apolipoprotein E polymorphism with outcome after head injury. Lancet 1997; 350: 1069-1071
23. Catto AJ, McCormack LJ, Mansfield MW, et al. Apolipoprotein E polymorphism in cerebrovascular disease. Acta Neurol Scand 2000; 101: 399-404
24. McCarron MO, Muir KW, Weir CJ, et al. The apolipoprotein E E4 allele and outcome in cerebrovascular disease. Stroke 1998; 29: 1882-1887
25. McCarron MO, Muir KW, Nicoll JA, et al. Prospective study of apolipoprotein E genotype and functional outcome following ischemic stroke. Arch Neurol 2000; 57: 1480-1484
26. Weir CJ, McCarron MO, Muir KW, et al. Apolipoprotein E genotype, coagulation, and survival following acute stroke. Neurology 2001; 57: 1097-1100
27. World Health Organization. International Classification of Impairments, Disabilities and Handicaps, Geneva: World Health Organization, 1980
28. Multicenter trial of hemodilution in ischemic stroke: Background and study protocol. Scandinavian Stroke Study Group. Stroke 1985; 16: 885-890
29. van Swieten JC, Koudstaal PJ, Visser MC, et al. Interobserver agreement for the assessment of handicap in stroke patients. Stroke 1988; 19: 604-607
30. Bamford J, Sandercock P, Dennis M, et al. A prospective study of acute cerebrovascular disease in the community: the Oxfordshire Community Stroke Project-1981-1986, 2. Incidence, case fatality rates and overall outcome at one year of cerebral infarction, primary intracerebral and subarachnoid haemorrhage. J Neurol Neurosurg Psychiatry 1990; 53: 16-22
31. Foulkes MA, Wolf PA, Price TR, et al. The Stroke Data Bank: Design, methods, and baseline characteristics. Stroke 1988; 19: 547-554
32. Hixson JE, Vernier DT. Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with Hhal. J Lipid Res 1990; 31: 545-548
33. Carolei A, Marini C, Di Napoli M, et al. High stroke incidence in the prospective community-based L'Aquila Registry (1994-1998): First year's results. Stroke 1997; 28: 2500-2506
34. Broderick JP, Philips SJ, O'Fallon WM, et al. Relationship of cardiac disease to stroke occurrence, recurrence, and mortality. Stroke 1992; 23: 1250-1256
35. Korv J, Roose M, Kaasik AE. Stroke registry of Tartu, Estonia, from 1991 through 1993. Cerebrovasc Dis 1997; 7: 154-162
36. McCarron MO, Delong D, Alberts MJ. APOE genotype as a risk factor for ischemic cerebrovascular disease: A meta-analysis. Neurology 1999; 53: 1308-1311
37. Siest G, Pillot T, Regis-Bailly A, et al. Apolipoprotein E: An important gene and protein to follow in laboratory medicine. Clin Chem 1995; 41: 1068-1086